>Mercado de vacunas en Europa, por composición (vacunas combinadas, vacunas mono), tipo (vacunas de subunidades, recombinantes, polisacáridas y conjugadas, vacunas vivas atenuadas, vacunas inactivadas, vacunas toxoides, vacunas de ADN), tipo (vacuna de rutina, vacuna recomendada, vacuna requerida), edad de administración (vacuna pediátrica, vacuna para adultos), enfermedades (enfermedad neumocócica, sarampión, paperas y varicela, DPT, hepatitis, influenza, fiebre tifoidea, meningococo, rabia, encefalitis japonesa, fiebre amarilla, otras), vía de administración (inyectable, oral, nasal), usuario final (hospitales comunitarios, hospitales, centros especializados, clínicas, otros), canal de distribución (farmacia hospitalaria, farmacia minorista, farmacia en línea), país (Alemania, Reino Unido, Francia, Italia, España, Países Bajos, Rusia, Suiza, Turquía, Austria, Noruega, Hungría, Lituania, Irlanda, Polonia y resto de Europa: tendencias de la industria y pronóstico hasta 2028
Análisis y perspectivas del mercado: mercado de vacunas en Europa
Se espera que el mercado de vacunas de Europa gane crecimiento de mercado en el período de pronóstico de 2021 a 2028. Data Bridge Market Research analiza que el mercado está creciendo con una CAGR del 6,5% en el período de pronóstico de 2021 a 2028 y se espera que alcance los USD 61.988,47 millones para 2028. La alta prevalencia de enfermedades crónicas como la gripe y las enfermedades infecciosas bacterianas y el lanzamiento de vacunas más nuevas son los principales impulsores que impulsaron la demanda del mercado en el período de pronóstico.
Las vacunas tienen características tales como la creciente necesidad de productos seguros y eficaces que afectarán el lanzamiento de nuevos productos por parte de los fabricantes al mercado, lo que aumentará su demanda, y el aumento de la inversión en investigación y desarrollo conducirá al crecimiento del mercado. Actualmente se están llevando a cabo varios estudios de investigación que se espera que creen una ventaja competitiva para que los fabricantes desarrollen productos de vacunas nuevos e innovadores, lo que se espera que brinde varias otras oportunidades en el mercado de las vacunas. Sin embargo, se espera que las dificultades asociadas con el transporte y la producción de vacunas y el miedo entre los pacientes en relación con las inyecciones y los pinchazos con agujas limiten el crecimiento del mercado en el período de pronóstico.
Las vacunas son preparaciones biológicas que proporcionan inmunidad adquirida activa contra una enfermedad en particular. La vacuna contiene una sustancia o agentes que se asemejan a los microorganismos que causan enfermedades y se preparan a partir de patógenos debilitados o muertos, como bacterias o virus. Cuando se inyectan patógenos debilitados o muertos en un cuerpo, estos microbios hacen que las células B, que son células de memoria del sistema inmunológico, reconozcan al patógeno y, en el futuro, si el mismo patógeno ataca al cuerpo, actuará contra él. Se han descubierto vacunas para varios tipos de enfermedades infecciosas que prevalecen en el mundo, como la enfermedad neumocócica, el sarampión, las paperas, la rubéola, la hepatitis, la gripe, la fiebre tifoidea, la varicela y la rabia, entre otras.
El informe del mercado de vacunas proporciona detalles sobre la participación de mercado, los nuevos desarrollos y el análisis de la cartera de productos, el impacto de los actores del mercado nacional y localizado, analiza las oportunidades en términos de bolsas de ingresos emergentes, cambios en las regulaciones del mercado, aprobaciones de productos, decisiones estratégicas, lanzamientos de productos, expansiones geográficas e innovaciones tecnológicas en el mercado. Para comprender el análisis y el escenario del mercado, comuníquese con nosotros para obtener un informe de analista; nuestro equipo lo ayudará a crear una solución de impacto en los ingresos para lograr su objetivo deseado.
Alcance y tamaño del mercado mundial de vacunas
El mercado de vacunas se clasifica en ocho segmentos notables que se basan en la composición, el tipo, la clase, la edad de administración, las enfermedades, la vía de administración, el usuario final y el canal de distribución. El crecimiento entre segmentos le ayuda a analizar nichos de crecimiento y estrategias para abordar el mercado y determinar sus áreas de aplicación principales y la diferencia en sus mercados objetivo.
- En función de la composición, el mercado de vacunas se segmenta en vacunas combinadas y monovacunas. En 2021, el segmento de vacunas combinadas domina el mercado porque una sola vacuna combinada puede utilizarse para prevenir diferentes tipos de enfermedades.
- Según el tipo, el mercado de vacunas se segmenta en vacunas de subunidades, recombinantes, polisacáridas y conjugadas , vacunas vivas atenuadas, vacunas inactivadas , vacunas toxoides y vacunas de ADN. En 2021, el segmento de vacunas de subunidades, recombinantes, polisacáridas y conjugadas domina el mercado porque estas vacunas se pueden utilizar para casi todo el mundo con el fin de mejorar la respuesta inmunitaria. Además, el aumento de las inversiones de las empresas y el aumento del apoyo gubernamental para el desarrollo de nuevas vacunas están actuando como otro factor para acelerar el crecimiento del mercado.
- En función del tipo, el mercado de vacunas se segmenta en vacunas de rutina, vacunas recomendadas y vacunas obligatorias. En 2021, el segmento de vacunas de rutina domina el mercado porque los profesionales de la salud y las autoridades gubernamentales están muy centrados en la vacunación infantil para romper el ciclo intergeneracional de la pobreza.
- En función de la edad de administración, el mercado de vacunas se segmenta en vacunas pediátricas y vacunas para adultos. En 2021, el segmento de vacunas pediátricas domina el mercado debido al creciente lanzamiento de programas de inmunización y campañas de vacunación infantil.
- En función de las enfermedades, el mercado de vacunas se segmenta en enfermedad neumocócica, sarampión, paperas y varicela, DPT, hepatitis, influenza, fiebre tifoidea, meningococo, rabia, encefalitis japonesa , fiebre amarilla y otras. En 2021, el segmento de enfermedades neumocócicas domina el mercado debido a la creciente prevalencia de la infección por neumonía, más común en niños y que también afecta a una gran población de adultos.
- Según la vía de administración, el mercado de vacunas se segmenta en inyectables, orales y nasales. En 2021, el segmento inyectable domina el mercado porque las vacunas administradas por vía parenteral brindan una respuesta sistémica a largo plazo de forma controlada.
- En función del usuario final, el mercado de vacunas se segmenta en hospitales comunitarios, hospitales, centros especializados, clínicas y otros. En 2021, el segmento de hospitales comunitarios domina el mercado debido al creciente enfoque del gobierno en la vacunación y al aumento del lanzamiento de campañas de vacunación masiva.
- Según el canal de distribución, el mercado de vacunas se segmenta en farmacias hospitalarias, farmacias minoristas y farmacias en línea. En 2021, el segmento de farmacias hospitalarias domina el mercado porque la mayoría de las personas visitan hospitales comunitarios y hospitales que solían adquirir vacunas directamente en las farmacias hospitalarias cercanas.
Análisis del mercado de vacunas a nivel de país
Se analiza el mercado de vacunas y se proporciona información sobre el tamaño del mercado en función de la composición, el tipo, la clase, la edad de administración, las enfermedades, la vía de administración, el usuario final y el canal de distribución.
Los países cubiertos en el informe del mercado de vacunas son Alemania, Reino Unido, Francia, Italia, España, Países Bajos, Rusia, Suiza, Turquía, Austria, Noruega, Hungría, Lituania, Irlanda, Polonia y el resto de Europa.
Se espera que el segmento de vacunas de rutina en la región de Europa crezca a la tasa más alta en el período de pronóstico de 2021 a 2028 debido al aumento de los ensayos clínicos y el desarrollo de la investigación para la prevención de enfermedades relacionadas con la gripe entre los niños. Alemania lidera el crecimiento del mercado de Asia-Pacífico y el segmento de vacunas de rutina domina en este país debido al aumento del consumo y la producción de vacunas. El Reino Unido es el país de más rápido crecimiento debido al aumento de la iniciativa gubernamental para la vacunación.
La sección de países del informe también proporciona factores de impacto de mercado individuales y cambios en la regulación en el mercado a nivel nacional que afectan las tendencias actuales y futuras del mercado. Los puntos de datos como nuevas ventas, ventas de reemplazo, demografía del país, leyes regulatorias y aranceles de importación y exportación son algunos de los principales indicadores utilizados para pronosticar el escenario del mercado para países individuales. Además, la presencia y disponibilidad de marcas globales y sus desafíos enfrentados debido a la competencia grande o escasa de las marcas locales y nacionales, el impacto de los canales de venta se consideran al proporcionar un análisis de pronóstico de los datos del país.
La presencia de productos en desarrollo y la creciente conciencia sobre la vacunación están impulsando el crecimiento del mercado de las vacunas
El mercado de vacunas también le proporciona un análisis detallado del mercado para el crecimiento de cada país en la industria de vacunas con las ventas de medicamentos de vacunas, el impacto del avance en la tecnología de vacunas y los cambios en los escenarios regulatorios con su apoyo al mercado de vacunas. Los datos están disponibles para el período histórico de 2010 a 2019.
Análisis del panorama competitivo y de la cuota de mercado de las vacunas
El panorama competitivo del mercado de vacunas proporciona detalles por competidor. Los detalles incluidos son la descripción general de la empresa, las finanzas de la empresa, los ingresos generados, el potencial de mercado, la inversión en investigación y desarrollo, las nuevas iniciativas de mercado, los sitios e instalaciones de producción, las fortalezas y debilidades de la empresa, el lanzamiento de productos, los procesos de prueba de productos, las aprobaciones de productos, las patentes, la amplitud y amplitud de los productos, el dominio de las aplicaciones y la curva de supervivencia de la tecnología. Los puntos de datos anteriores proporcionados solo están relacionados con el enfoque de la empresa relacionado con el mercado de vacunas.
Las principales empresas que se dedican a las vacunas son Emergent BioSolutions Inc., Dynavax Technologies, Valneva SE, Bavarian Nordic, Merck Sharp & Dohme Corp. (una subsidiaria de Merck & Co., Inc.), Takeda Pharmaceutical Company Limited, Seqirus (una subsidiaria de CSL Limited), Abbott, AstraZeneca, Sanofi, Pfizer Inc., Janssen Global Services, LLC (una subsidiaria de Johnson & Johnson Services, Inc., F. Hoffmann-La Roche Ltd, DAIICHI SANKYO COMPANY, LIMITED, ALK, Panacea Biotec Ltd, BAXTER VACCINES (una subsidiaria de Baxter), GlaxoSmithKline plc., Serum Institute of India Pvt., entre otras.
Muchos lanzamientos y acuerdos de productos también son iniciados por empresas de todo el mundo, lo que también está acelerando el mercado de las vacunas.
- En agosto de 2020, Bavarian Nordic lanzó la vacuna RABAVERT en EE. UU. Junto con esto, la empresa impulsó las capacidades de distribución y comercialización de la vacuna. La vacuna RABAVERT está indicada para la vacunación de la población de todas las edades. Esta iniciativa ayudó a la empresa a lograr un crecimiento lucrativo en el mercado de las vacunas.
- En julio de 2020, Dynavax Technologies colaboró con Mount Sinai para el desarrollo de una vacuna universal contra la gripe. En virtud de la colaboración, Mount Sinai utilizará el adyuvante CpG fabricado por Dynavax Technologies Corporation para el desarrollo de una nueva vacuna. Para el desarrollo de la nueva vacuna, Mount Sinai producirá hemaglutinina quimérica (cHA) diseñada para proteger contra todas las diferentes cepas de la gripe. Esta iniciativa impulsó los ingresos de la empresa al proporcionar su plataforma patentada para el desarrollo de nuevas vacunas.
La colaboración, el lanzamiento de productos, la expansión comercial, los premios y reconocimientos, las empresas conjuntas y otras estrategias de los actores del mercado están mejorando el mercado de la empresa en el mercado de vacunas, lo que también brinda el beneficio para que la organización mejore su oferta de vacunas.
SKU-
Obtenga acceso en línea al informe sobre la primera nube de inteligencia de mercado del mundo
- Panel de análisis de datos interactivo
- Panel de análisis de empresas para oportunidades con alto potencial de crecimiento
- Acceso de analista de investigación para personalización y consultas
- Análisis de la competencia con panel interactivo
- Últimas noticias, actualizaciones y análisis de tendencias
- Aproveche el poder del análisis de referencia para un seguimiento integral de la competencia
Tabla de contenido
- introduction
- OBJECTIVES OF THE STUDY
- MARKET DEFINITION
- OVERVIEW of EUROPE vaccines MARKET
- LIMITATIONs
- MARKETS COVERED
- MARKET SEGMENTATION
- MARKETS COVERED
- geographical scope
- years considered for the study
- currency and pricing
- DBMR TRIPOD DATA VALIDATION MODEL
- MULTIVARIATE MODELLING
- composition LIFELINE CURVE
- primary interviews with key opinion leaders
- DBMR MARKET POSITION GRID
- vendor share analysis
- secondary sourcEs
- assumptions
- EXECUTIVE SUMMARY
- premium insight
- epidemiology
- Pipeline analysis
- Europe VACCINES Market: Laws and regulations
- Europe VACCINES Market: logistics of vaccines
- Cold Chain Storage:
- Regulations Associated With Vaccine Supply
- Process of Logistics
- CHALLENGES IN LOGISTICS
- Challenges faced by India for upcoming COVID 19 Vaccine:
- Challenges faced by Latin America for upcoming vaccine:
- Challenges Faced by Nigeria for vaccine logistics:
- Market Overview
- Drivers
- growing immunization programs and campaigns
- HIGH PREVALENCE OF CHRONIC CONDITION SUCH AS FLU AND BACTERIAL INFECTIOUS DISEAsES
- IMPROVEMENT IN TREATMENT
- launch of newer vaccines
- increasing government support
- RESTRAINTS
- UNAVAILABILITY OF REGISTERED VACCINES
- HIGH COST AND DIFFERENCES IN PRICING OF THE VACCINES
- DIFFICULTIES ASSOCIATED WITH TRANSPORT AND PRODUCTION OF VACCINES
- opportunities
- STRATEGIC INITIATIVES BY the MARKET PLAYERS
- presence of pipeline products
- Rise in expenditure in healthcare sector
- increasing awareness for vaccination
- challenges
- Side Effects Caused by Vaccines
- fear among patients related to injections and needle sticks
- product recall
- Impact of COVID-19 on Europe Vaccines Market
- PRICE IMPACT
- IMPACT ON SUPPLY CHAIN
- IMPACT ON DEMAND
- CONCLUSION
- Europe vaccines MARKET, BY composition
- overview
- COMBINATION VACCINES
- MONO VACCINES
- Europe vaccines MARKET, BY type
- overview
- SUBUNIT, RECOMBINANT, POLYSACCHARIDE, AND CONJUGATE VACCINES
- Pneumococcal Disease
- HIB (Haemophilus Influenzae Type B) Disease
- HPV (Human Papilloma Virus)
- Hepatitis B
- Meningococcal
- Shingles
- Whooping Cough
- OTHERS
- LIVE-ATTENUTAED VACCINES
- Rotavirus
- Measles
- mumps
- Rubella
- SMALLPOX
- yellow fever
- OTHERS
- INACTIVATED VACCINES
- Flu (Shot Only)
- Polio (Shot Only)
- Hepatitis A
- Rabies
- Others
- TOXOID VACCINES
- diphtheria, Tetanus & Pertussis (DTP)
- Others
- DNA VACCINES
- Europe vaccines MARKET, BY kind
- overview
- ROUTINE VACCINE
- PNEUMOCOCCAL
- DIPHTHERIA
- HIB (Haemophilus Influenzae Type B) Disease
- MEASLES
- MUMPS
- HEPATITIS B
- RUBELLA
- POLIO
- OTHERS
- RECOMMENDED VACCINES
- TYPHOID FEVER VACCINES
- HEPATITIS A
- RABIES
- JAPANESE ENCEPHALITIS
- TICK-BORNE ENCEPHALITIS
- CHOLERA
- OTHERS
- REQUIRED VACCINES
- Meningococcal
- Yellow Fever
- Others
- Europe vaccines MARKET, BY Age of Administration
- overview
- PEDIATRIC VACCINES
- PNEUMOCOCCAL
- MEASLES, MUMPS, AND, RUBELLA
- Diphtheria, Tetanus & Pertusis (DPT)
- ROTAVIRUS
- MENINGOCOCCAL
- VARICELLA
- POLIO
- TUBERCULOSIS
- malaria
- OTHERS
- ADULT VACCINES
- inlfuenza
- HPV (Human Papilloma Virus)
- Typhoid
- Hepatitis B
- Japanese Encephalitis
- YELLOW FEVER
- HIV
- CANCER
- OTHERS
- Europe vaccines MARKET, BY diseases
- overview
- pneumoccocal disease
- Measles, Mumps & Rubella
- DPT
- hepatitis
- Influenza
- Typhoid
- Meningococcal
- Varicella
- Rabies
- Japanese Encephalitis
- Yellow Fever
- others
- Europe vaccines MARKET, BY route of administration
- overview
- INJECTABLE
- Intramuscular
- Subcutaneous
- Intradermal
- ORAL
- NASAL
- Europe vaccines MARKET, BY end user
- overview
- COMMUNITY HOSPITALS
- HOSPITALS
- SPECIALTY CENTRES
- CLINICS
- OTHERS
- Europe vaccines MARKET, BY distribution channel
- overview
- HOSPITAL PHARMACy
- RETAIL PHARMACy
- ONLINE PHARMACy
- EUROPE vaccines MARKET, by Geography
- EUROPE
- germany
- france
- U.K.
- italy
- spain
- NETHERLAND
- russia
- Switzerland
- TURKEY
- Austria
- norway
- hungary
- lithuania
- Ireland
- poland
- rest of europe
- Europe Vaccines Market: COMPANY landscape
- company share analysis: europe
- company profile
- glaxosmithkline plc.
- COMPANY SNAPSHOt
- revenue analysis
- company share analysis
- product portfolio
- recent developmentS
- swot analysis
- Merck Sharp & Dohme Corp. (a subsidiary of Merck & Co., Inc.)
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- company share analysis
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- swot analys
- Sanofi
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- company share analysis
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- swot analys
- Pfizer Inc.
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- company share analysis
- pRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- swot anal
- Abbott
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- company share analysis
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- ALK
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- Altimmune
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- AstraZeneca
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- Bavarian Nordic
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- BAXTER VACCINES (A Subsidiary of Baxter)
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- BHARAT BIOTECH
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- Bio Farma
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- Biological E Limited
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- DAIICHI SANKYO COMPANY, LIMITED
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- Dynavax Technologies
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- Emergent BioSolutions Inc.
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- F. Hoffmann-La Roche Ltd
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- Janssen Europe Services, LLC (A Subsidiary of Johnson & Johnson Services, Inc.)
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- lanzhou biological products research institute co., ltd.,
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- Panacea Biotec Ltd
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- Seqirus (A Subsidiary of CSL Limited)
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- swot analysis
- serum institute of india pvt. ltd.
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- Takeda Pharmaceutical Company Limited
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- Valneva SE
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- questionnaire
- related reports
Lista de Tablas
TABLE 1 Europe vaccines Market, pipeline analysis
TABLE 2 REGULATIONS IMPOSED BY SEVERAL REGULATORY AGENCIES IN DIFFERENT REGIONS
TABLE 3 Recommended Temperature and Storage Length At Various Level of The Cold Chain.
TABLE 4 PROCEDURES for reporting to Unicef vaccine arrivals.
TABLE 5 logisitcs process acorss different regions.
TABLE 6 the u.s. funding for gavi (2015-2019)
TABLE 7 Price of the vaccines between the U.S. and developing countries
TABLE 8 vaccines under clinical trial
TABLE 9 the side effects related to the vaccines
TABLE 10 INCREASE IN OPERATIONAL COST COMPONENTS DUE TO COVID-19
TABLE 11 TOTAL NUMBER OF CASES FOR MEASLES REPORTED BY THE TEN COUNTRIES
TABLE 12 Europe Vaccines Market, By Composition, 2019-2028 (USD Million)
TABLE 13 Europe Combination Vaccines in Vaccines Market, By Region, 2019-2028 (USD Million)
TABLE 14 Europe Mono Vaccines in Vaccines Market, By Region, 2019-2028 (USD Million)
TABLE 15 Europe Vaccines Market, By Type, 2019-2028 (USD Million)
TABLE 16 Europe Subunit, Recombinant, Polysaccharide & Conjugated Vaccines in Vaccines Market, By Region, 2019-2028 (USD Million)
TABLE 17 Europe Live-Attenuated Vaccines in Vaccines Market, By Region, 2019-2028 (USD Million)
TABLE 18 Europe Live-Attenuated Vaccines in Vaccines Market, By Type, 2019-2028 (USD Million)
TABLE 19 Europe Inactivated Vaccines in Vaccines Market, By Region, 2019-2028 (USD Million)
TABLE 20 Europe Inactivated Vaccines in Vaccines Market, By Type, 2019-2028 (USD Million)
TABLE 21 Europe Toxoid Vaccines in Vaccines Market, By Type, 2019-2028 (USD Million)
TABLE 22 Europe Toxoid Vaccines in Vaccines Market, By Region, 2019-2028 (USD Million)
TABLE 23 Europe vaccines Market, By kind, 2019-2028 (USD Million)
TABLE 24 Europe Routine Vaccine in Vaccines Market, By Region, 2019-2028 (USD Million)
TABLE 25 Europe Routine Vaccine in Vaccines Market, By Kind, 2019-2028 (USD Million)
TABLE 26 Europe Recommended Vaccine in Vaccines Market, By Region, 2019-2028 (USD Million)
TABLE 27 Europe Recommended Vaccine in Vaccines Market, By Kind, 2019-2028 (USD Million)
TABLE 28 Europe Required Vaccine in Vaccines Market, By Region, 2019-2028 (USD Million)
TABLE 29 Europe Required Vaccine in Vaccines Market, By Kind, 2019-2028 (USD Million)
TABLE 30 Europe Vaccines Market, By Age of Administration, 2019-2028 (USD Million)
TABLE 31 Europe Pediatric Vaccine in Vaccines Market, By Region, 2019-2028 (USD Million)
TABLE 32 Europe Pediatric Vaccine in Vaccines Market, By Age of Administration, 2019-2028 (USD Million)
TABLE 33 Europe Adult Vaccine in Vaccines Market, By Region, 2019-2028 (USD Million)
TABLE 34 Europe Adult in Vaccines Market, By Age of Administration, 2019-2028 (USD Million)
TABLE 35 Europe pneumococcal disease in vaccines Market, By Region, 2017-2028 (USD Million)
TABLE 36 Europe measles, mumps & rubella in vaccines Market, By Region, 2017-2028 (USD Million)
TABLE 37 Europe DPT in vaccines Market, By Region, 2017-2028 (USD Million)
TABLE 38 Europe hepatitis in vaccines Market, By Region, 2017-2028 (USD Million)
TABLE 39 Europe influenza in vaccines Market, By Region, 2017-2028 (USD Million)
TABLE 40 Europe typhoid in vaccines Market, By Region, 2017-2028 (USD Million)
TABLE 41 Europe meningococcal in vaccines Market, By Region, 2017-2028 (USD Million)
TABLE 42 Europe varicella in vaccines Market, By Region, 2017-2028 (USD Million)
TABLE 43 Europe rabies in vaccines Market, By Region, 2017-2028 (USD Million)
TABLE 44 Europe Japanese encephalitis in vaccines Market, By Region, 2017-2028 (USD Million)
TABLE 45 Europe yellow fever in vaccines Market, By Region, 2017-2028 (USD Million)
TABLE 46 Europe other in vaccines Market, By Region, 2017-2028 (USD Million)
TABLE 47 Europe Vaccines Market, By Route of Administration, 2019-2028 (USD Million)
TABLE 48 Europe Injectable in Vaccines Market, By Region, 2019-2028 (USD Million)
TABLE 49 Europe Injectable in Vaccines Market, By Route of Administration, 2019-2028 (USD Million)
TABLE 50 Europe Oral in Vaccines Market, By Region, 2019-2028 (USD Million)
TABLE 51 Europe Nasal in Vaccines Market, By Region, 2019-2028 (USD Million)
TABLE 52 Europe Vaccines Market, By End User, 2019-2028 (USD Million)
TABLE 53 Europe Community Hospitals in Vaccines Market, By Region, 2019-2028 (USD Million)
TABLE 54 Europe Hospitals in Vaccines Market, By Region, 2019-2028 (USD Million)
TABLE 55 Europe Specialty Centres in Vaccines Market, By Region, 2019-2028 (USD Million)
TABLE 56 Europe Clinics in Vaccines Market, By Region, 2019-2028 (USD Million)
TABLE 57 Europe others in Vaccines Market, By Region, 2019-2028 (USD Million)
TABLE 58 Europe Vaccines Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 59 Europe Hospital Pharmacy in Vaccines Market, By Region, 2019-2028 (USD Million)
TABLE 60 Europe Retail Pharmacy in Vaccines Market, By Region, 2019-2028 (USD Million)
TABLE 61 Europe Online Pharmacy in Vaccines Market, By Region, 2019-2028 (USD Million)
TABLE 62 EUROPE VACCINES MARKET, BY COUNTRY, 2019-2028 (USD MILLION)
TABLE 63 EUROPE VACCINES Market, By COMPOSITION, 2019-2028 (USD Million)
TABLE 64 EUROPE VACCINES Market, By Type, 2019-2028 (Usd million)
TABLE 65 EUROPE Subunit, Recombinant, Polysaccharide & Conjugated Vaccines in vaccines Market, By Type, 2019-2028 (USD Million)
TABLE 66 EUROPE Live-Attenuated Vaccines in Vaccines Market, By Type, 2019-2028 (USD Million)
TABLE 67 EUROPE Inactivated Vaccines in VACCINES Market, By type, 2019-2028 (USD Million)
TABLE 68 EUROPE Toxoid Vaccines in VACCINES Market, By Type, 2019-2028 (USD Million)
TABLE 69 EUROPE VACCINES Market, By kind, 2019-2028 (USD Million)
TABLE 70 EUROPE Routine Vaccine in VACCINES Market, By kind, 2019-2028 (USD Million)
TABLE 71 EUROPE Recommended Vaccine in VACCINES Market, By kind, 2019-2028 (USD Million)
TABLE 72 EUROPE Required Vaccine in VACCINES Market, By kind, 2019-2028 (USD Million)
TABLE 73 EUROPE VACCINES Market, By age of administration, 2019-2028 (USD Million)
TABLE 74 EUROPE pediatric Vaccine in VACCINES Market, By age of administration, 2019-2028 (USD Million)
TABLE 75 EUROPE adult Vaccine in VACCINES Market, By age of administration, 2019-2028 (USD Million)
TABLE 76 EUROPE VACCINES Market, By disease, 2019-2028 (USD Million)
TABLE 77 EUROPE VACCINES Market, By route of administration, 2019-2028 (USD Million)
TABLE 78 EUROPE injectable in VACCINES Market, By route of administration, 2019-2028 (USD Million)
TABLE 79 EUROPE VACCINES Market, By end user, 2019-2028 (USD Million)
TABLE 80 EUROPE VACCINES Market, By Distribution channel, 2019-2028 (USD Million)
TABLE 81 GERMANY VACCINES Market, By composition, 2019-2028 (USD Million)
TABLE 82 GERMANY VACCINES Market, By Type, 2019-2028 (Usd million)
TABLE 83 GERMANY subunit, recombinant, polysaccharide & conjugated vaccines in VACCINES Market, By Type, 2019-2028 (USD Million)
TABLE 84 GERMANY live-attenuated vaccines in VACCINES Market, By Type, 2019-2028 (USD Million)
TABLE 85 GERMANY inactivated vaccines in VACCINES Market, By type, 2019-2028 (USD Million)
TABLE 86 GERMANY toxoid vaccines in VACCINES Market, By type, 2019-2028 (USD Million)
TABLE 87 GERMANY VACCINES Market, By kind, 2019-2028 (USD Million)
TABLE 88 GERMANY routine vaccines in VACCINES Market, By kind, 2019-2028 (USD Million)
TABLE 89 GERMANY recommended vaccines in VACCINES Market, By kind, 2019-2028 (USD Million)
TABLE 90 GERMANY Required Vaccine in VACCINES Market, By kind, 2019-2028 (USD Million)
TABLE 91 GERMANY VACCINES Market, By age of administration, 2019-2028 (USD Million)
TABLE 92 GERMANY pediatric Vaccine in VACCINES Market, By age of administration, 2019-2028 (USD Million)
TABLE 93 GERMANY adult Vaccine in VACCINES Market, By age of administration, 2019-2028 (USD Million)
TABLE 94 GERMANY VACCINES Market, By disease, 2019-2028 (USD Million)
TABLE 95 GERMANY VACCINES Market, By route of administration, 2019-2028 (USD Million)
TABLE 96 GERMANY VACCINES Market, By route of administration, 2019-2028 (USD Million)
TABLE 97 GERMANY VACCINES Market, By end user, 2019-2028 (USD Million)
TABLE 98 GERMANY injectable in VACCINES Market, By Distribution channel, 2019-2028 (USD Million)
TABLE 99 FRANCE VACCINES Market, By composition, 2019-2028 (USD Million)
TABLE 100 FRANCE VACCINES Market, By Type, 2019-2028 (Usd million)
TABLE 101 FRANCE subunit, recombinant, polysaccharide & conjugated vaccines in VACCINES Market, By Type, 2019-2028 (USD Million)
TABLE 102 FRANCE live-attenuated vaccines in VACCINES Market, By Type, 2019-2028 (USD Million)
TABLE 103 FRANCE inactivated vaccines in VACCINES Market, By type, 2019-2028 (USD Million)
TABLE 104 FRANCE toxoid vaccines in VACCINES Market, By type, 2019-2028 (USD Million)
TABLE 105 FRANCE VACCINES Market, By kind, 2019-2028 (USD Million)
TABLE 106 FRANCE routine vaccines in VACCINES Market, By kind, 2019-2028 (USD Million)
TABLE 107 FRANCE recommended vaccines in VACCINES Market, By kind, 2019-2028 (USD Million)
TABLE 108 FRANCE Required Vaccine in VACCINES Market, By kind, 2019-2028 (USD Million)
TABLE 109 FRANCE VACCINES Market, By age of administration, 2019-2028 (USD Million)
TABLE 110 FRANCE pediatric Vaccine in VACCINES Market, By age of administration, 2019-2028 (USD Million)
TABLE 111 FRANCE adult Vaccine in VACCINES Market, By age of administration, 2019-2028 (USD Million)
TABLE 112 FRANCE VACCINES Market, By disease, 2019-2028 (USD Million)
TABLE 113 FRANCE VACCINES Market, By route of administration, 2019-2028 (USD Million)
TABLE 114 FRANCE injectable in VACCINES Market, By route of administration, 2019-2028 (USD Million)
TABLE 115 FRANCE VACCINES Market, By end user, 2019-2028 (USD Million)
TABLE 116 FRANCE VACCINES Market, By Distribution channel, 2019-2028 (USD Million)
TABLE 117 U.K. VACCINES Market, By composition, 2019-2028 (USD Million)
TABLE 118 U.K. VACCINES Market, By Type, 2019-2028 (Usd million)
TABLE 119 U.K. subunit, recombinant, polysaccharide & conjugated vaccines in VACCINES Market, By Type, 2019-2028 (USD Million)
TABLE 120 U.K. live-attenuated vaccines in VACCINES Market, By Type, 2019-2028 (USD Million)
TABLE 121 U.K. inactivated vaccines in VACCINES Market, By type, 2019-2028 (USD Million)
TABLE 122 U.K. toxoid vaccines in VACCINES Market, By type, 2019-2028 (USD Million)
TABLE 123 U.K. VACCINES Market, By kind, 2019-2028 (USD Million)
TABLE 124 U.K. routine vaccines in VACCINES Market, By kind, 2019-2028 (USD Million)
TABLE 125 U.K. recommended vaccines in VACCINES Market, By kind, 2019-2028 (USD Million)
TABLE 126 U.K. Required Vaccine in VACCINES Market, By kind, 2019-2028 (USD Million)
TABLE 127 U.K. VACCINES Market, By age of administration, 2019-2028 (USD Million)
TABLE 128 U.K. pediatric Vaccine in VACCINES Market, By age of administration, 2019-2028 (USD Million)
TABLE 129 U.K. adult Vaccine in VACCINES Market, By age of administration, 2019-2028 (USD Million)
TABLE 130 U.K. VACCINES Market, By diseases, 2019-2028 (USD Million)
TABLE 131 U.K. vACCINES Market, By route of administration, 2019-2028 (USD Million)
TABLE 132 U.K. injectable in VACCINES Market, By route of administration, 2019-2028 (USD Million)
TABLE 133 U.K. VACCINES Market, By end user, 2019-2028 (USD Million)
TABLE 134 U.K. VACCINES Market, By Distribution channel, 2019-2028 (USD Million)
TABLE 135 italy VACCINES Market, By composition, 2019-2028 (USD Million)
TABLE 136 italy VACCINES Market, By Type, 2019-2028 (Usd million)
TABLE 137 ITALY subunit, recombinant, polysaccharide & conjugated vaccines in VACCINES Market, By Type, 2019-2028 (USD Million)
TABLE 138 ITALY live-attenuated vaccines in VACCINES Market, By Type, 2019-2028 (USD Million)
TABLE 139 ITALY inactivated vaccines in VACCINES Market, By type, 2019-2028 (USD Million)
TABLE 140 ITALY toxoid vaccines in VACCINES Market, By type, 2019-2028 (USD Million)
TABLE 141 italy VACCINES Market, By kind, 2019-2028 (USD Million)
TABLE 142 ITALY routine vaccines in VACCINES Market, By kind, 2019-2028 (USD Million)
TABLE 143 italy recommended vaccines in VACCINES Market, By kind, 2019-2028 (USD Million)
TABLE 144 italy Required Vaccine in VACCINES Market, By kind, 2019-2028 (USD Million)
TABLE 145 italy VACCINES Market, By age of administration, 2019-2028 (USD Million)
TABLE 146 italy pediatric Vaccine in VACCINES Market, By age of administration, 2019-2028 (USD Million)
TABLE 147 italy adult Vaccine in VACCINES Market, By age of administration, 2019-2028 (USD Million)
TABLE 148 italy VACCINES Market, By diseases, 2019-2028 (USD Million)
TABLE 149 italy vACCINES Market, By route of administration, 2019-2028 (USD Million)
TABLE 150 italy injectable in VACCINES Market, By route of administration, 2019-2028 (USD Million)
TABLE 151 italy VACCINES Market, By end user, 2019-2028 (USD Million)
TABLE 152 italy VACCINES Market, By Distribution channel, 2019-2028 (USD Million)
TABLE 153 spain VACCINES Market, By composition, 2019-2028 (USD Million)
TABLE 154 SPAIN VACCINES Market, By Type, 2019-2028 (Usd million)
TABLE 155 SPAIN subunit, recombinant, polysaccharide & conjugated vaccines in VACCINES Market, By Type, 2019-2028 (USD Million)
TABLE 156 SPAIN live-attenuated vaccines in VACCINES Market, By Type, 2019-2028 (USD Million)
TABLE 157 SPAIN inactivated vaccines in VACCINES Market, By type, 2019-2028 (USD Million)
TABLE 158 SPAIN toxoid vaccines in VACCINES Market, By type, 2019-2028 (USD Million)
TABLE 159 SPAIN VACCINES Market, By kind, 2019-2028 (USD Million)
TABLE 160 SPAIN routine vaccines in VACCINES Market, By kind, 2019-2028 (USD Million)
TABLE 161 SPAIN recommended vaccines in VACCINES Market, By kind, 2019-2028 (USD Million)
TABLE 162 SPAIN Required Vaccine in VACCINES Market, By kind, 2019-2028 (USD Million)
TABLE 163 SPAIN VACCINES Market, By age of administration, 2019-2028 (USD Million)
TABLE 164 SPAIN pediatric Vaccine in VACCINES Market, By age of administration, 2019-2028 (USD Million)
TABLE 165 SPAIN adult Vaccine in VACCINES Market, By age of administration, 2019-2028 (USD Million)
TABLE 166 SPAIN VACCINES Market, By diseases, 2019-2028 (USD Million)
TABLE 167 SPAIN vACCINES Market, By route of administration, 2019-2028 (USD Million)
TABLE 168 SPAIN injectable in VACCINES Market, By route of administration, 2019-2028 (USD Million)
TABLE 169 SPAIN VACCINES Market, By end user, 2019-2028 (USD Million)
TABLE 170 SPAIN VACCINES Market, By Distribution channel, 2019-2028 (USD Million)
TABLE 171 NETHERLAND VACCINES Market, By composition, 2019-2028 (USD Million)
TABLE 172 netherland VACCINES Market, By Type, 2019-2028 (Usd million)
TABLE 173 netherland subunit, recombinant, polysaccharide & conjugated vaccines in VACCINES Market, By Type, 2019-2028 (USD Million)
TABLE 174 netherland live-attenuated vaccines in VACCINES Market, By Type, 2019-2028 (USD Million)
TABLE 175 netherland inactivated vaccines in VACCINES Market, By type, 2019-2028 (USD Million)
TABLE 176 netherland toxoid vaccines in VACCINES Market, By type, 2019-2028 (USD Million)
TABLE 177 netherland VACCINES Market, By kind, 2019-2028 (USD Million)
TABLE 178 netherland routine vaccines in VACCINES Market, By kind, 2019-2028 (USD Million)
TABLE 179 netherland recommended vaccines in VACCINES Market, By kind, 2019-2028 (USD Million)
TABLE 180 netherland Required Vaccine in VACCINES Market, By kind, 2019-2028 (USD Million)
TABLE 181 netherland VACCINES Market, By age of administration, 2019-2028 (USD Million)
TABLE 182 netherland pediatric Vaccine in VACCINES Market, By age of administration, 2019-2028 (USD Million)
TABLE 183 netherland adult Vaccine in VACCINES Market, By age of administration, 2019-2028 (USD Million)
TABLE 184 netherland VACCINES Market, By diseases, 2019-2028 (USD Million)
TABLE 185 netherland vACCINES Market, By route of administration, 2019-2028 (USD Million)
TABLE 186 netherland injectable in VACCINES Market, By route of administration, 2019-2028 (USD Million)
TABLE 187 NETHERLAND VACCINES Market, By end user, 2019-2028 (USD Million)
TABLE 188 NETHERLAND VACCINES Market, By Distribution channel, 2019-2028 (USD Million)
TABLE 189 russia VACCINES Market, By composition, 2019-2028 (USD Million)
TABLE 190 russia VACCINES Market, By Type, 2019-2028 (Usd million)
TABLE 191 russia subunit, recombinant, polysaccharide & conjugated vaccines in VACCINES Market, By Type, 2019-2028 (USD Million)
TABLE 192 russia live-attenuated vaccines in VACCINES Market, By Type, 2019-2028 (USD Million)
TABLE 193 russia inactivated vaccines in VACCINES Market, By type, 2019-2028 (USD Million)
TABLE 194 russia toxoid vaccines in VACCINES Market, By type, 2019-2028 (USD Million)
TABLE 195 russia VACCINES Market, By kind, 2019-2028 (USD Million)
TABLE 196 russia routine vaccines in VACCINES Market, By kind, 2019-2028 (USD Million)
TABLE 197 russia recommended vaccines in VACCINES Market, By kind, 2019-2028 (USD Million)
TABLE 198 russia Required Vaccine in VACCINES Market, By kind, 2019-2028 (USD Million)
TABLE 199 russia VACCINES Market, By age of administration, 2019-2028 (USD Million)
TABLE 200 russia pediatric Vaccine in VACCINES Market, By age of administration, 2019-2028 (USD Million)
TABLE 201 russia adult Vaccine in VACCINES Market, By age of administration, 2019-2028 (USD Million)
TABLE 202 russia VACCINES Market, By diseases, 2019-2028 (USD Million)
TABLE 203 russia vACCINES Market, By route of administration, 2019-2028 (USD Million)
TABLE 204 russia injectable in VACCINES Market, By route of administration, 2019-2028 (USD Million)
TABLE 205 russia VACCINES Market, By end user, 2019-2028 (USD Million)
TABLE 206 russia VACCINES Market, By Distribution channel, 2019-2028 (USD Million)
TABLE 207 Switzerland VACCINES Market, By composition, 2019-2028 (USD Million)
TABLE 208 Switzerland VACCINES Market, By Type, 2019-2028 (Usd million)
TABLE 209 Switzerland subunit, recombinant, polysaccharide & conjugated vaccines in VACCINES Market, By Type, 2019-2028 (USD Million)
TABLE 210 Switzerland live-attenuated vaccines in VACCINES Market, By Type, 2019-2028 (USD Million)
TABLE 211 Switzerland inactivated vaccines in VACCINES Market, By type, 2019-2028 (USD Million)
TABLE 212 Switzerland toxoid vaccines in VACCINES Market, By type, 2019-2028 (USD Million)
TABLE 213 Switzerland VACCINES Market, By kind, 2019-2028 (USD Million)
TABLE 214 Switzerland routine vaccines in VACCINES Market, By kind, 2019-2028 (USD Million)
TABLE 215 Switzerland recommended vaccines in VACCINES Market, By kind, 2019-2028 (USD Million)
TABLE 216 Switzerland Required Vaccine in VACCINES Market, By kind, 2019-2028 (USD Million)
TABLE 217 Switzerland VACCINES Market, By age of administration, 2019-2028 (USD Million)
TABLE 218 Switzerland pediatric Vaccine in VACCINES Market, By age of administration, 2019-2028 (USD Million)
TABLE 219 Switzerland adult Vaccine in VACCINES Market, By age of administration, 2019-2028 (USD Million)
TABLE 220 Switzerland VACCINES Market, By diseases, 2019-2028 (USD Million)
TABLE 221 Switzerland vACCINES Market, By route of administration, 2019-2028 (USD Million)
TABLE 222 Switzerland injectable in VACCINES Market, By route of administration, 2019-2028 (USD Million)
TABLE 223 Switzerland VACCINES Market, By end user, 2019-2028 (USD Million)
TABLE 224 Switzerland VACCINES Market, By Distribution channel, 2019-2028 (USD Million)
TABLE 225 turkey VACCINES Market, By composition, 2019-2028 (USD Million)
TABLE 226 turkey VACCINES Market, By Type, 2019-2028 (Usd million)
TABLE 227 turkey subunit, recombinant, polysaccharide & conjugated vaccines in VACCINES Market, By Type, 2019-2028 (USD Million)
TABLE 228 turkey live-attenuated vaccines in VACCINES Market, By Type, 2019-2028 (USD Million)
TABLE 229 turkey inactivated vaccines in VACCINES Market, By type, 2019-2028 (USD Million)
TABLE 230 turkey toxoid vaccines in VACCINES Market, By type, 2019-2028 (USD Million)
TABLE 231 turkey VACCINES Market, By kind, 2019-2028 (USD Million)
TABLE 232 turkey routine vaccines in VACCINES Market, By kind, 2019-2028 (USD Million)
TABLE 233 turkey recommended vaccines in VACCINES Market, By kind, 2019-2028 (USD Million)
TABLE 234 turkey Required Vaccine in VACCINES Market, By kind, 2019-2028 (USD Million)
TABLE 235 turkey VACCINES Market, By age of administration, 2019-2028 (USD Million)
TABLE 236 turkey pediatric Vaccine in VACCINES Market, By age of administration, 2019-2028 (USD Million)
TABLE 237 turkey adult Vaccine in VACCINES Market, By age of administration, 2019-2028 (USD Million)
TABLE 238 turkey VACCINES Market, By diseases, 2019-2028 (USD Million)
TABLE 239 turkey vACCINES Market, By route of administration, 2019-2028 (USD Million)
TABLE 240 turkey injectable in VACCINES Market, By route of administration, 2019-2028 (USD Million)
TABLE 241 turkey VACCINES Market, By end user, 2019-2028 (USD Million)
TABLE 242 turkey VACCINES Market, By Distribution channel, 2019-2028 (USD Million)
TABLE 243 austria VACCINES Market, By composition, 2019-2028 (USD Million)
TABLE 244 austria VACCINES Market, By Type, 2019-2028 (Usd million)
TABLE 245 austria subunit, recombinant, polysaccharide & conjugated vaccines in VACCINES Market, By Type, 2019-2028 (USD Million)
TABLE 246 austria live-attenuated vaccines in VACCINES Market, By Type, 2019-2028 (USD Million)
TABLE 247 austria inactivated vaccines in VACCINES Market, By type, 2019-2028 (USD Million)
TABLE 248 austria toxoid vaccines in VACCINES Market, By type, 2019-2028 (USD Million)
TABLE 249 austria VACCINES Market, By kind, 2019-2028 (USD Million)
TABLE 250 austria routine vaccines in VACCINES Market, By kind, 2019-2028 (USD Million)
TABLE 251 austria recommended vaccines in VACCINES Market, By kind, 2019-2028 (USD Million)
TABLE 252 austria Required Vaccine in VACCINES Market, By kind, 2019-2028 (USD Million)
TABLE 253 austria VACCINES Market, By age of administration, 2019-2028 (USD Million)
TABLE 254 austria pediatric Vaccine in VACCINES Market, By age of administration, 2019-2028 (USD Million)
TABLE 255 austria adult Vaccine in VACCINES Market, By age of administration, 2019-2028 (USD Million)
TABLE 256 austria VACCINES Market, By diseases, 2019-2028 (USD Million)
TABLE 257 austria vACCINES Market, By route of administration, 2019-2028 (USD Million)
TABLE 258 austria injectable in VACCINES Market, By route of administration, 2019-2028 (USD Million)
TABLE 259 austria VACCINES Market, By end user, 2019-2028 (USD Million)
TABLE 260 austria VACCINES Market, By Distribution channel, 2019-2028 (USD Million)
TABLE 261 Norway VACCINES Market, By composition, 2019-2028 (USD Million)
TABLE 262 norway VACCINES Market, By Type, 2019-2028 (Usd million)
TABLE 263 norway subunit, recombinant, polysaccharide & conjugated vaccines in VACCINES Market, By Type, 2019-2028 (USD Million)
TABLE 264 norway live-attenuated vaccines in VACCINES Market, By Type, 2019-2028 (USD Million)
TABLE 265 norway inactivated vaccines in VACCINES Market, By type, 2019-2028 (USD Million)
TABLE 266 norway toxoid vaccines in VACCINES Market, By type, 2019-2028 (USD Million)
TABLE 267 norway VACCINES Market, By kind, 2019-2028 (USD Million)
TABLE 268 norway routine vaccines in VACCINES Market, By kind, 2019-2028 (USD Million)
TABLE 269 norway recommended vaccines in VACCINES Market, By kind, 2019-2028 (USD Million)
TABLE 270 norway Required Vaccine in VACCINES Market, By kind, 2019-2028 (USD Million)
TABLE 271 norway VACCINES Market, By age of administration, 2019-2028 (USD Million)
TABLE 272 norway pediatric Vaccine in VACCINES Market, By age of administration, 2019-2028 (USD Million)
TABLE 273 norway adult Vaccine in VACCINES Market, By age of administration, 2019-2028 (USD Million)
TABLE 274 norway VACCINES Market, By diseases, 2019-2028 (USD Million)
TABLE 275 norway vACCINES Market, By route of administration, 2019-2028 (USD Million)
TABLE 276 norway injectable in VACCINES Market, By route of administration, 2019-2028 (USD Million)
TABLE 277 norway VACCINES Market, By end user, 2019-2028 (USD Million)
TABLE 278 norway VACCINES Market, By Distribution channel, 2019-2028 (USD Million)
TABLE 279 hungary VACCINES Market, By composition, 2019-2028 (USD Million)
TABLE 280 hungary VACCINES Market, By Type, 2019-2028 (Usd million)
TABLE 281 hungary subunit, recombinant, polysaccharide & conjugated vaccines in VACCINES Market, By Type, 2019-2028 (USD Million)
TABLE 282 hungary live-attenuated vaccines in VACCINES Market, By Type, 2019-2028 (USD Million)
TABLE 283 hungary inactivated vaccines in VACCINES Market, By type, 2019-2028 (USD Million)
TABLE 284 hungary toxoid vaccines in VACCINES Market, By type, 2019-2028 (USD Million)
TABLE 285 hungary VACCINES Market, By kind, 2019-2028 (USD Million)
TABLE 286 hungary routine vaccines in VACCINES Market, By kind, 2019-2028 (USD Million)
TABLE 287 hungary recommended vaccines in VACCINES Market, By kind, 2019-2028 (USD Million)
TABLE 288 hungary Required Vaccine in VACCINES Market, By kind, 2019-2028 (USD Million)
TABLE 289 hungary VACCINES Market, By age of administration, 2019-2028 (USD Million)
TABLE 290 hungary pediatric Vaccine in VACCINES Market, By age of administration, 2019-2028 (USD Million)
TABLE 291 hungary adult Vaccine in VACCINES Market, By age of administration, 2019-2028 (USD Million)
TABLE 292 hungary VACCINES Market, By diseases, 2019-2028 (USD Million)
TABLE 293 hungary vACCINES Market, By route of administration, 2019-2028 (USD Million)
TABLE 294 hungary injectable in VACCINES Market, By route of administration, 2019-2028 (USD Million)
TABLE 295 hungary VACCINES Market, By end user, 2019-2028 (USD Million)
TABLE 296 hungary VACCINES Market, By Distribution channel, 2019-2028 (USD Million)
TABLE 297 Lithuania VACCINES Market, By composition, 2019-2028 (USD Million)
TABLE 298 Lithuania VACCINES Market, By Type, 2019-2028 (Usd million)
TABLE 299 Lithuania subunit, recombinant, polysaccharide & conjugated vaccines in VACCINES Market, By Type, 2019-2028 (USD Million)
TABLE 300 Lithuania live-attenuated vaccines in VACCINES Market, By Type, 2019-2028 (USD Million)
TABLE 301 Lithuania inactivated vaccines in VACCINES Market, By type, 2019-2028 (USD Million)
TABLE 302 Lithuania toxoid vaccines in VACCINES Market, By type, 2019-2028 (USD Million)
TABLE 303 Lithuania VACCINES Market, By kind, 2019-2028 (USD Million)
TABLE 304 Lithuania routine vaccines in VACCINES Market, By kind, 2019-2028 (USD Million)
TABLE 305 Lithuania recommended vaccines in VACCINES Market, By kind, 2019-2028 (USD Million)
TABLE 306 Lithuania Required Vaccine in VACCINES Market, By kind, 2019-2028 (USD Million)
TABLE 307 Lithuania VACCINES Market, By age of administration, 2019-2028 (USD Million)
TABLE 308 Lithuania pediatric Vaccine in VACCINES Market, By age of administration, 2019-2028 (USD Million)
TABLE 309 Lithuania adult Vaccine in VACCINES Market, By age of administration, 2019-2028 (USD Million)
TABLE 310 Lithuania VACCINES Market, By diseases, 2019-2028 (USD Million)
TABLE 311 Lithuania vACCINES Market, By route of administration, 2019-2028 (USD Million)
TABLE 312 Lithuania injectable in VACCINES Market, By route of administration, 2019-2028 (USD Million)
TABLE 313 Lithuania VACCINES Market, By end user, 2019-2028 (USD Million)
TABLE 314 Lithuania VACCINES Market, By Distribution channel, 2019-2028 (USD Million)
TABLE 315 ireland VACCINES Market, By composition, 2019-2028 (USD Million)
TABLE 316 ireland VACCINES Market, By Type, 2019-2028 (Usd million)
TABLE 317 ireland subunit, recombinant, polysaccharide & conjugated vaccines in VACCINES Market, By Type, 2019-2028 (USD Million)
TABLE 318 ireland live-attenuated vaccines in VACCINES Market, By Type, 2019-2028 (USD Million)
TABLE 319 ireland inactivated vaccines in VACCINES Market, By type, 2019-2028 (USD Million)
TABLE 320 ireland toxoid vaccines in VACCINES Market, By type, 2019-2028 (USD Million)
TABLE 321 ireland VACCINES Market, By kind, 2019-2028 (USD Million)
TABLE 322 ireland routine vaccines in VACCINES Market, By kind, 2019-2028 (USD Million)
TABLE 323 ireland recommended vaccines in VACCINES Market, By kind, 2019-2028 (USD Million)
TABLE 324 ireland Required Vaccine in VACCINES Market, By kind, 2019-2028 (USD Million)
TABLE 325 ireland VACCINES Market, By age of administration, 2019-2028 (USD Million)
TABLE 326 ireland pediatric Vaccine in VACCINES Market, By age of administration, 2019-2028 (USD Million)
TABLE 327 ireland adult Vaccine in VACCINES Market, By age of administration, 2019-2028 (USD Million)
TABLE 328 ireland VACCINES Market, By diseases, 2019-2028 (USD Million)
TABLE 329 ireland vACCINES Market, By route of administration, 2019-2028 (USD Million)
TABLE 330 ireland injectable in VACCINES Market, By route of administration, 2019-2028 (USD Million)
TABLE 331 ireland VACCINES Market, By end user, 2019-2028 (USD Million)
TABLE 332 Ireland VACCINES Market, By Distribution channel, 2019-2028 (USD Million)
TABLE 333 poland VACCINES Market, By composition, 2019-2028 (USD Million)
TABLE 334 poland VACCINES Market, By Type, 2019-2028 (Usd million)
TABLE 335 poland subunit, recombinant, polysaccharide & conjugated vaccines in VACCINES Market, By Type, 2019-2028 (USD Million)
TABLE 336 poland live-attenuated vaccines in VACCINES Market, By Type, 2019-2028 (USD Million)
TABLE 337 poland inactivated vaccines in VACCINES Market, By type, 2019-2028 (USD Million)
TABLE 338 poland toxoid vaccines in VACCINES Market, By type, 2019-2028 (USD Million)
TABLE 339 poland VACCINES Market, By kind, 2019-2028 (USD Million)
TABLE 340 poland routine vaccines in VACCINES Market, By kind, 2019-2028 (USD Million)
TABLE 341 poland recommended vaccines in VACCINES Market, By kind, 2019-2028 (USD Million)
TABLE 342 poland Required Vaccine in VACCINES Market, By kind, 2019-2028 (USD Million)
TABLE 343 poland VACCINES Market, By age of administration, 2019-2028 (USD Million)
TABLE 344 poland pediatric Vaccine in VACCINES Market, By age of administration, 2019-2028 (USD Million)
TABLE 345 poland adult Vaccine in VACCINES Market, By age of administration, 2019-2028 (USD Million)
TABLE 346 poland VACCINES Market, By diseases, 2019-2028 (USD Million)
TABLE 347 poland vACCINES Market, By route of administration, 2019-2028 (USD Million)
TABLE 348 poland injectable in VACCINES Market, By route of administration, 2019-2028 (USD Million)
TABLE 349 poland VACCINES Market, By end user, 2019-2028 (USD Million)
TABLE 350 poland VACCINES Market, By Distribution channel, 2019-2028 (USD Million)
TABLE 351 rest of europe VACCINES Market, By composition, 2019-2028 (USD Million)
Lista de figuras
FIGURE 1 Europe VACCINES MARKET: SEGMENTATION
FIGURE 2 EUROPE VACCINES MARKET : DATA TRIANGULATION
FIGURE 3 Europe Vaccines Market: DROC ANALYSIS
FIGURE 4 Europe Vaccines market: Europe VS REGIONAL MARKET ANALYSIS
FIGURE 5 Europe Vaccines Market: COMPANY RESEARCH ANALYSIS
FIGURE 6 EUROPE Vaccines MARKET: MULTIVARIATE MODELLING
FIGURE 7 EUROPE Vaccines MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 8 EUROPE VACCINES MARKET: DBMR MARKET POSITION GRID
FIGURE 9 EUROPE VACCINES MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 Europe Vaccines market: SEGMENTATION
FIGURE 11 Growing Immunization Programs and Campaigns and High Prevalence of Chronic Condition such as Flu and Bacterial Infectious Diseases are DRIVing THE Europe Vaccines MARKET IN THE FORECAST PERIOD OF 2021 to 2028
FIGURE 12 combination vaccines SEGMENT is expected to account for the largest share of the Europe VACCINES MARKET in 2021 & 2028
FIGURE 13 FDA Regulatory Review Process of Vaccines
FIGURE 14 AEFI ORGANIZATIONAL STRUCTURES
FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGEs OF EUROPE vaccines market
FIGURE 16 Europe vaccination coverage in the world (2019)
FIGURE 17 Pediatric deaths caused by influenza in the U.S. (2017 – 2020)
FIGURE 18 Europe prevalence of hbv infection worldwide in 2018
FIGURE 19 Healthcare expenditure per capita, 2018
FIGURE 20 TOTAL NUMBER OF CASES FOR MEASLES REPORTED BY THE TEN COUNTRIES
FIGURE 21 Europe vaccines market: BY composition, 2021
FIGURE 22 Europe vaccines market: BY composition, 2019-2028 (USD Million)
FIGURE 23 Europe vaccines market: BY composition, CAGR (2021-2028)
FIGURE 24 Europe vaccines market: BY composition, LIFELINE CURVE
FIGURE 25 Europe vaccines market: BY type, 2021
FIGURE 26 Europe vaccines market: BY type, 2019-2028 (USD Million)
FIGURE 27 Europe vaccines market: BY type, CAGR (2021-2028)
FIGURE 28 Europe vaccines market: BY type, LIFELINE CURVE
FIGURE 29 Europe vaccines market: BY kind, 2019
FIGURE 30 Europe vaccines market: BY kind, 2019-2028 (USD Million)
FIGURE 31 Europe vaccines market: BY kind, CAGR (2021-2028)
FIGURE 32 Europe vaccines market: BY kind, LIFELINE CURVE
FIGURE 33 Europe vaccines market: BY age of administration, 2019
FIGURE 34 Europe vaccines market: BY age of administration, 2019-2028 (USD Million)
FIGURE 35 Europe vaccines market: BY age of administration, CAGR (2021-2028)
FIGURE 36 Europe vaccines market: BY age of administration, LIFELINE CURVE
FIGURE 37 Europe vaccines market: BY diseases, 2020
FIGURE 38 Europe vaccines market: BY diseases, 2019-2028 (USD Million)
FIGURE 39 Europe vaccines market: BY diseases, CAGR (2021-2028)
FIGURE 40 Europe vaccines market: BY diseases, LIFELINE CURVE
FIGURE 41 Europe vaccines market: BY route of administration, 2019
FIGURE 42 Europe vaccines market: BY route of administration, 2019-2028 (USD Million)
FIGURE 43 Europe vaccines market: BY route of administration, CAGR (2021-2028)
FIGURE 44 Europe vaccines market: BY route of administration, LIFELINE CURVE
FIGURE 45 Europe vaccines market: BY end user, 2019
FIGURE 46 Europe vaccines market: BY end user, 2019-2028 (USD Million)
FIGURE 47 Europe vaccines market: BY end user, CAGR (2021-2028)
FIGURE 48 Europe vaccines market: BY end user, LIFELINE CURVE
FIGURE 49 Europe vaccines market: BY distribution channel, 2019
FIGURE 50 Europe vaccines market: BY distribution channel, 2019-2028 (USD Million)
FIGURE 51 Europe vaccines market: BY distribution channel, CAGR (2021-2028)
FIGURE 52 Europe vaccines market: BY distribution channel, LIFELINE CURVE
FIGURE 53 EUROPE VACCINES market: SNAPSHOT (2020)
FIGURE 54 EUROPE VACCINES market: BY COUNTRY (2020)
FIGURE 55 EUROPE VACCINES market: BY COUNTRY (2021 & 2028)
FIGURE 56 EUROPE VACCINES market: BY COUNTRY (2020 & 2028)
FIGURE 57 EUROPE VACCINES market: BY type (2021-2028)
FIGURE 58 EUROPE Vaccines Market: company share 2020 (%)
Metodología de investigación
La recopilación de datos y el análisis del año base se realizan utilizando módulos de recopilación de datos con muestras de gran tamaño. La etapa incluye la obtención de información de mercado o datos relacionados a través de varias fuentes y estrategias. Incluye el examen y la planificación de todos los datos adquiridos del pasado con antelación. Asimismo, abarca el examen de las inconsistencias de información observadas en diferentes fuentes de información. Los datos de mercado se analizan y estiman utilizando modelos estadísticos y coherentes de mercado. Además, el análisis de la participación de mercado y el análisis de tendencias clave son los principales factores de éxito en el informe de mercado. Para obtener más información, solicite una llamada de un analista o envíe su consulta.
La metodología de investigación clave utilizada por el equipo de investigación de DBMR es la triangulación de datos, que implica la extracción de datos, el análisis del impacto de las variables de datos en el mercado y la validación primaria (experto en la industria). Los modelos de datos incluyen cuadrícula de posicionamiento de proveedores, análisis de línea de tiempo de mercado, descripción general y guía del mercado, cuadrícula de posicionamiento de la empresa, análisis de patentes, análisis de precios, análisis de participación de mercado de la empresa, estándares de medición, análisis global versus regional y de participación de proveedores. Para obtener más información sobre la metodología de investigación, envíe una consulta para hablar con nuestros expertos de la industria.
Personalización disponible
Data Bridge Market Research es líder en investigación formativa avanzada. Nos enorgullecemos de brindar servicios a nuestros clientes existentes y nuevos con datos y análisis que coinciden y se adaptan a sus objetivos. El informe se puede personalizar para incluir análisis de tendencias de precios de marcas objetivo, comprensión del mercado de países adicionales (solicite la lista de países), datos de resultados de ensayos clínicos, revisión de literatura, análisis de mercado renovado y base de productos. El análisis de mercado de competidores objetivo se puede analizar desde análisis basados en tecnología hasta estrategias de cartera de mercado. Podemos agregar tantos competidores sobre los que necesite datos en el formato y estilo de datos que esté buscando. Nuestro equipo de analistas también puede proporcionarle datos en archivos de Excel sin procesar, tablas dinámicas (libro de datos) o puede ayudarlo a crear presentaciones a partir de los conjuntos de datos disponibles en el informe.